Summary
Six manic patients were treated with high doses of d-propranolol or d- and dl-propranolol in a double-blind, placebo controlled study. The following variables were measured: propranolol dosage, propranolol serum concentration, pulse frequency, blood pressure, and psychotic behavior. In all cases an improvement was noticed. High dosages were necessary to obtain sufficient effect. The antimanic property of d-propranolol was approximately 50% smaller than the antimanic property of dl-propranolol. We conclude that at least some part of the antimanic action of beta-blockers is independent from the beta-blocking property.
Zusammenfassung
Im Rahmen einer doppelblind durchgeführten, placebokontrollierten Studie wurden sechs manische Patienten mit hohen Dosen doder d- und dl-Propranolol behandelt. Dabei wurden folgende Variablen gemessen: Propranolol-Dosis, Propranolol-Serumkonzentration, Pulsfrequenz, Blutdruck und Psychopathologie. In allen Fällen konnte eine klinische Besserung festgestellt werden, aber hohe Dosen waren erforderlich, um einen befriedigenden therapeutischen Effekt zu erreichen. Die antimanische Wirksamkeit von d-Propranolol erschien, verglichen mit der von dl-Propranolol, um etwa 50% geringer. Aus diesem Ergebnis kann geschlossen werden, daß wenigstens ein Teil der antimanischen Wirksamkeit von Beta-Blockern unabhängig ist von den beta-blockierenden Eigenschaften dieser Substanzen.
Similar content being viewed by others
References
Anden, N. E., Strömbom, U.: Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia 38, 91–103 (1974)
Atsmon, A.: Early observations of the effect of propranolol on psychiatric patients. In: Neuropsychiatric effects of adrenergic beta-receptor blocking agents, Carlsson, C., Engel, J., Hansson, L. (eds.), pp. 86–91. München-Berlin-Wien: Urban and Schwarzenberg 1976
Atsmon, A., Blum, J.: Treatment of acute porphyria variegata with propranolol. Lancet 1970 I, 196–197
Atsmon, A., Blum, J., Wijsenbeek, H., Maoz, B., Steiner, M., Ziegelman, G.: The short-term effect of adrenergic blocking agents in a small group of psychotic patients. Psychiatr. Neurol. Neurochir. 74, 251–258 (1971)
Atsmon, A., Blum, J., Steiner, M., Latz, A., Wijsenbeek, H.: Further studies with propranolol in psychotic patients. Psychopharmacologia 27, 249–254 (1972)
Auriol, B., Palandjian, N., Bord, N., Vals, A.: Les beta bloquants en psychiatrie. Nouv. Presse Med. 1, 1439–1452 (1972)
Carlsson, C., Engel, J., Hansson, L. (eds.): Neuro-psychiatric effects of adrenergic beta-receptor blocking agents. München-Berlin-Wien: Urban and Schwarzenberg 1976
Delini-Stula, A., Meier, M.: Inhibitory effects of propranolol and oxprenolol on excitation induced by a mao inhibitor and reserpine in the mouse. Neuropharmacology 15, 383–388 (1976)
Elliott, F. A.: Propranolol for the control of belligerent behavior following acute brain damage. Ann. Neurol. 1, 489–491 (1977)
Emrich, H. M., Zerssen, D. v., Möller, H. J., Kissling, W., Cording, C., Schietsch, E., Riedel, J.: Action of propranolol in mania: comparison of effects of the d- and the l-stereoisomer. Pharmakopsychiat. Neuropsychopharmakol. 12, 295–304 (1979)
Engel, J., Liljequist, S.: Behavioural effects of β-receptor blocking agents in experimental animals. In: Neuro-psychiatric effects of adrenergic beta receptor blocking agents, Carlsson, C., Engel, J., Hansson, L. (eds.), pp. 45–53. München-Berlin-Wien: Urban and Schwarzenberg 1976
Floru, L.: Die Anwendung β-blockierender Substanzen in der Psychiatrie und Neurologie. Fortschr. Neurol. Psychiatr. 45, 112–127 (1977)
Gardos, G., Cole, J. O., Volicer, L., Orzack, M., Oliff, A. C.: A dose-response study of propranolol in chronic schizophrenics. Curr. Ther. Res. Clin. Exp. 15, 314–323 (1973)
Goldman, H. W., Lehr, D., Friedman, E.: Antagonistic effects of alpha and beta adrenergically coded hypothalamic neurons on consummatory behaviour in the rat. Nature 231, 453–455 (1971)
Greenblatt, D. J., Koch-Weser, J.: Adverse reactions to β-adrenergic receptor blocking drugs: a report from the Boston Collaborative Drug Surveillance Program. Drugs 7, 118–129 (1974)
Greenblatt, D. J., Shader, R. I.: On the psychopharmacology of beta-adrenergic blockade. Curr. Ther. Res. Clin. Exp. 14, 615–625 (1972)
Grüter, W.: Psychoses and beta-blockers. In: Beta-Blockers and the central nervous system, Kiel-holz, P. (ed.), pp. 240–244. Bern-Stuttgart-Wien: Huber 1977
Gruzelier, J. H., Yorkston, N. J.: Propranolol and schizophrenia: Objective evidence of efficacy. In: The biological basis of schizophrenia, M. G. Hemmings, W. A. Hemmings (eds.), pp. 127–149. Lancaster: MTP Press 1978
Hanssen, T., Heyden, T., Sundberg, I., Wetterberg, I., Eneroth, P.: Decrease in serum-prolactin after propranolol in schizophrenia. Lancet 1978I, 101–102
Hinshelwood, R. D.: Hallucinations and propranolol. Br. Med. J. 1969II, 445
Honigfeld, G.: NOSIE-30: History and current Status of its use in pharmacopsychiatric research. In: Psychological measurements in psychopharmacology. Mod. Probl. Pharmacopsychiatry 7, 238–263 (1974)
Honigfeld, G., Klett, C. J.: The nurses' observation scale for inpatient evaluation. A new ward behavior rating scale. J. Clin. Psychol. 21, 65–71 (1965)
Jacobi, P.: Untersuchungen zur Faktorenstruktur, Zuverlässigkeit und Gültigkeit einer deutschen Bearbeitung der IMPS nach Lorr. Med. Diss., Univ. Hamburg 1974
Jefferson, J. W.: Beta-adrenergic receptor blocking drugs in psychiatry. Arch. Gen. Psychiatry 31, 681–691 (1974)
Keller, M. F.: Nebenwirkungen, Kontraindikationen und antagonistische Maßnahmen bei der Anwendung von Beta-Rezeptoren-Blockern (BRB). Schweiz. Med. Rundschau 62, 987–991 (1973)
Koella, W. P.: Anatomical, physiological, and pharmacological findings relevant to the central nervous effect of the beta-blockers. In: Beta-blockers and the central nervous system, Kiel-holz, P. (ed.), pp. 21–35. Bern-Stuttgart-Wien: Huber 1977
Kral, P. A., Omer, V. V. St.: Beta-adrenergic receptor involvement in the mediation of learned taste aversions. Psychopharmacology 26, 79–83 (1972)
Lefkowitz, R. J., Caron, M. C., Mukherjee, C., Mickey, J., Tate, R.: Beta-adrenergic receptors: direct identification and physiological regulation. In: Cell membrane receptors for viruses and antibodies, polypeptide hormones, and small molecules, Beers, R. F., Bassett, E. G. (eds.). New York: Raven Press 1976
Leibowitz, S. F.: Hypothalamic beta-adrenergic satiety system antagonizes an alpha-adrenergic hunger system in the rat. Nature 226, 963–964 (1970)
Lorr, M., Klett, C. J., McNair, D. M., Lasky, J. J.: Inpatient multidimensional psychiatric scale. Manual. Palo Alto/Calif.: Psychological Press 1963
Margules, D. L.: Beta-adrenergic receptors in the hypothalamus for learned and unlearned taste aversions. J. Comp. Physiol. Psychol. 73, 13–21 (1970)
Margules, D. L.: Alpha and beta-adrenergic receptors in amygdala: reciprocal inhibitors and facilitators of punished operant behaviour. Eur. J. Pharmacol. 16, 21–26 (1971)
Masuoka, D., Hansson, E.: Autoradiographic distribution studies of adrenergic blocking agents. II. 1-Propranolol, a beta-receptor-type blocker. Acta Pharmacol. Toxicol. (Kbh.) 25, 447–455 (1967)
Modestin, J.: Beta-Rezeptorenblocker in der Psychiatrie. Fortschr. Neurol. Psychiatr. 44, 579–596 (1976)
Mombour, W.: Syndrome bei psychiatrischen Erkrankungen. Eine vergleichende Untersuchung mit Hilfe von zwei Schätzskalen für den psychopathologischen Befund (IMPS und AMP-Skala). Arch. Psychiatr. Nervenkr. 219, 331–350 (1974)
Mombour, W., Gammel, G., Heyse, H., Zerssen, D. v.: Die Objektivierung psychiatrischer Syndrome durch multifaktorielle Analyse des psychopathologischen Befundes. Nervenarzt 44, 352–358 (1973)
Orzack, M. H., Branconnier, R., Gardos, G.: CNS effects of propranolol in man. Psychopharmacology 29, 299–306 (1973)
Rackensperger, W., Gaupp, R., Mattke, D. J., Schwarz, D., Stutte, K. H.: Behandlung von akuten schizophrenen Psychosen mit Beta-Rezeptoren-Blockern. Arch. Psychiatr. Nervenkr. 219, 29–36 (1974)
Rackensperger, W., Fritsch, W., Schwarz, D., Stutte, K. H., Zerssen, D. v.: Wirkung des Beta-Rezeptoren-Blockers Propranolol auf Manien. Arch. Psychiatr. Nervenkr. 222, 223–243 (1976)
Reid, J. L., Lewis, P. J., Myers, M. G., Dollery, C. T.: Cardiovascular effects of intracerebroventricular d-, l-, and dl-propranolol in the conscious rabbit. J. Pharmacol. Exp. Ther. 188, 394–399 (1974)
Riedel, E., Emrich, H. M., Schröder, H. J.: Gaschromatographische Untersuchungen von Propranolol, ein Methodenvergleich. Arzneim. Forsch. (in press, 1979)
Roberts, E., Amacher, P. (eds.): Propranolol and schizophrenia. New York: Liss 1978
Saelens, D. A., Walle, T., Privitera, P. J., Knapp, D. R., Gaffney, T.: Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol. J. Pharmacol. Exp. Ther. 188, 86–92 (1974)
Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122, 509–522 (1965)
Schou, M.: Heutiger Stand der Rezidivprophylaxe bei endogenen affektiven Erkrankungen. Nervenarzt 45, 397–418 (1974)
Schwarz, D.: Die Anwendung von Beta-Rezeptoren-Blockern in Neurologie und Psychiatrie. In: Kardiale Sympathikolyse als therapeutisches Prinzip, Lydtin, H., Meesmann, W. (Hrsg.). Stuttgart: Georg Thieme 1975
Schwarz, D., Mertin, J.: Die Anwendung von Propranolol bei der akuten intermittierenden Porphyrie. Nervenarzt 44, 648–651 (1973)
Steiner, M., Blum, I., Wijsenbeek, H., Atsmon, A.: Results of the treatment of psychoses with propranolol. Kupat-Holim Yearb. 2 (1972)
Steiner, M., Latz, A., Blum, J., Atsmon, A., Wijsenbeek, H.: Propranolol versus chlorpromazine in the treatment of psychoses associated with childbearing. Psychiatr. Neurol. Neurochir. 76, 421–426 (1973)
Stephen, S. A.: Unwanted effects of propranolol. Am. J. Cardiol. 18, 463–472 (1966)
Vassout, A., Delini-Stula, A.: Effects de β-bloqueurs (Propranolol et Oxprenolol) et du Diazépam sur différents modèles d'agressivité chez le rat. J. Pharmacol. (Paris) 8, 1, 5–14 (1977)
Volk, W., Bier, W., Braun, J. P., Grüter, W., Spiegelberg, U.: Behandlung von erregten Psychosen mit einem Beta-Rezeptoren-Blocker (Oxprenolol) in hoher Dosierung. Nervenarzt 43, 491–492 (1972)
Volk, W., Bier, W., Braun, J. P., Spiegelberg, U.: Klinische Beobachtungen bei hochdosierter Behandlung endogener Psychosen mit einem Beta-Rezeptorenblocker. In: Kardiale Sympathikolyse als therapeutisches Prinzip, Lydtin, H., Meesmann, W. (Hrsg.). Stuttgart: Georg Thieme 1975
Voltolina, E. J., Thompson, S. I., Tisue, J.: Acute organic brain syndrome with propranolol. Clin. Toxicol. 4, 357–361 (1971)
Yorkston, N. J., Zaki, S. A., Malik, M. K., Morrison, R. C., Havard, C. W. H.: Propranolol in the control of schizophrenic symptoms. Br. Med. J. 1974IV, 633–635
Yorkston, N. J., Zaki, S. A., Themen, J. F. A., Havard, C. W. H.: Propranolol to control schizophrenic symptoms: 55 patients. In: Neuropsychiatric effects of adrenergic beta-receptor blocking agents, Carlsson, C., Engel, J., Hansson, L. (eds.), pp. 91–105. München-Berlin-Wien: Urban and Schwarzenberg 1976
Yorkston, N. J., Gruzelier, J. H., Zaki, S. A., Hollander, D., Pitcher, D. R., Sergeant, H. G. S.: Propranolol as an adjunct to the treatment of schizophrenia. Lancet 1977II, 575–578
Yorkston, N. J., Zaki, S. A., Havard, C. W. H.: Propranolol in the treatment of schizophrenia: an uncontrolled study with 55 adults. In: Propranolol in schizophrenia, Roberts, E., Amacher, P. (eds.). New York: Liss 1978
Zacharias, F. J., Cowen, K. J., Prestt, J., Vickers, J., Wall, B. G.: Propranolol in hypertension: a study of long-term therapy, 1964–1970. Am. Heart J. 83, 755–761 (1972)
Zerssen, D. v.: Beta-adrenergic blocking agents in the treatment of psychoses. A report on 17 cases. In: Neuro-psychiatric effects of adrenergic beta-receptor blocking agents, Carlsson, C., Engel, J., Hansson, L. (eds.), pp. 105–115. München-Berlin-Wien: Urban and Schwarzenberg 1976
Zerssen, D. v., Cording, C.: The measurement of change in endogenous affective disorders. Arch. Psychiatr. Nervenkr. 226, 95–112 (1978)
Author information
Authors and Affiliations
Additional information
Supported by the Fritz-Thyssen-Foundation, Cologne
Rights and permissions
About this article
Cite this article
Möller, H.J., Zerssen, D.v., Emrich, H.M. et al. Action of d-propranolol in manic psychoses. Arch. Psychiat. Nervenkr. 227, 301–317 (1979). https://doi.org/10.1007/BF00344815
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00344815